Skip to content

Infections of female genital tract

A study on reproductive tract infections / sexually transmitted infections among urban and peri urban women in North India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023954
Enrollment
440
Registered
2020-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Centre for Health Research and Development Society for Applied Studies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women enrolled in WINGS at the time of exit, that is, 18 months since enrolment in WINGS. 24 months after delivery for women with live birth

Exclusion criteria

Exclusion criteria: Non consent for participation

Design outcomes

Primary

MeasureTime frame
To determine the prevalence of laboratory confirmed RTI/STIs (Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Trichomonas vaginalis (TV), Candida albicans and bacterial vaginosis among symptomatic and asymptomatic women of reproductive age group (WRA) participating in WINGS.Timepoint: Atleast 14 days after their exit from the primary trial WINGS, for 2 groups of women - Women who complete 18 months of the pre and peri-conception phase without getting pregnant - Women with live birth, when the child is aged 24 months.

Secondary

MeasureTime frame
Assess the diagnostic validity of the current RTI/STI diagnostic and management practice (i.e., RTI/STI syndromic case management) in the WINGS relative to the gold standard etiologic diagnosis based on laboratory confirmation of RTI/STI) among women having of symptoms of RTI/STI Timepoint: Atleast 14 days after their exit from the primary trial WINGS, for 2 groups of women - Women who complete 18 months of the pre and peri-conception phase without getting pregnant - Women with live birth, when the child is aged 24 months. ;To identify demographic, behavioural, sexual and clinical factors associated with laboratory confirmed RTI/STI among women with symptoms such as vaginal discharge, itching and burning, rashes, pain lower abdomen, dyspareunia, ulcer or sore and swelling.Timepoint: Atleast 14 days after their exit from the primary trial WINGS, for 2 groups of women - Women who complete 18 months of the pre and peri-conception phase without getting pregnant - Women with live birth, when the child is aged 24 months.

Countries

India

Contacts

Public ContactNeeta Dhabhai

Centre for Health Research and Development, Society for Applied Studies

CHRD@sas.org.in011-46043751-55

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 20, 2026